Table 6. Multivariate analyses of clinicopathologic parameters on recurrence-free and overall survival in patients with squamous cell carcinoma.

	Squamous cell carcinoma (n=996)
		Recurrence-free survivala		Overall survivalb
Variables	N	OR (95% CI)	P-value	OR (95% CI)	P-value
Age, years
As continuous variable	996 (100)	1.05 (1.03–1.07)	<0.001	1.05 (1.03–1.07)	<0.001
Tumour size, cm
⩽2	463 (46.5)	Reference		Reference
2–4	416 (41.8)	2.25 (1.30–3.89)	0.004	2.12 (1.16–3.88)	0.015
4–6	94 (9.4)	4.51 (2.32–8.78)	<0.001	3.51 (1.64–7.50)	0.001
>6	23 (2.3)	6.36 (2.43–16.68)	<0.001	5.11 (1.73–15.14)	0.003
Parametrial involvement
No	906 (91.0)	Reference		Reference
Yes	90 (9.0)	1.78 (1.01–3.12)	0.046	2.17 (1.13–4.13)	0.019
Lymph node metastasis
No	860 (86.3)	Reference		Reference
Yes	136 (13.7)	1.86 (1.12–3.09)	0.017	2.11 (1.18–3.75)	0.012

Abbreviations: CI=confidence interval; LVSI=lymphovascular space invasion; OR=odds ratio.

^aThe analysis included age, FIGO stage, tumour size, depth of stromal invasion, parametrial involvement, LVSI, lymph node metastasis and adjuvant treatment.

^bThe analysis included age, tumour size, depth of stromal invasion, parametrial involvement, LVSI, lymph node metastasis and adjuvant treatment.